The Role of CK20, p53 and p63 in Differentiation of Some Urothelial Lesions of Urinary Bladder, Immunohistochemical Study

Journals Menu

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Open Journal of Pathology

ISSN Print: 2164-6775
ISSN Online: 2164-6783
www.scirp.org/journal/ojpathology
E-mail: ojpathology@scirp.org

Citations h5-index & Ranking*

Journals Menu

"The Role of CK20, p53 and p63 in Differentiation of Some Urothelial Lesions of Urinary Bladder, Immunohistochemical Study"
written by Sayed Abdel Raheem, Abdel Naby Saied, Rabee Al Shaer, Osama Mustafa, Ali Hassan Ali,
published by Open Journal of Pathology, Vol.4 No.4, 2014

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	Role of Cytokeratin 20 as a Predictive and Prognostic Marker in Urothelial Neoplasms
	Cureus, 2022

[2]	Evaluation of the prognostic value of CD117 and CK20 biomarkers in urinary bladder carcinoma
	مجله ی خون و سرطان ایران, 2022

[3]	Đánh giá một số đặc điểm nhuộm hóa mô miễn dịch trong ung thư biểu mô nhú đường niệu tại Bệnh viện Trung ương Quân đội 108
	Journal of 108-Clinical …, 2022

[4]	The Role p53 Protein Expression in Urothelial Neoplasm
	2021

[5]	Digital re-classification of equivocal dysplastic urothelial lesions using morphologic and immunohistologic analysis
	2020

[6]	Value of Ki-67 and p63 in Grading of Urothelial Neoplasms: An Immunohistochemical study
	2020

[7]	Overexpression of FOXO1A and p63 in urothelial carcinoma predict better prognosis.
	2019

[8]	Evolving concepts and use of immunohistochemical biomarkers in flat non-neoplastic urothelial lesions: WHO 2016 classification update with diagnostic algorithm
	Biomarkers, 2018

[9]	Papillary Urothelial Carcinoma of Urinary Bladder: A Comparative Study of The Immunohistochemical Staining Pattern of (Cytokeratin 20 and P16) And Its Relation to Tumor Grade and Other Factors
	International Journal of Medical Research Professionals, 2017

[10]	Significance of Her2/Neu, C-kit and P63 Immunohistochemical Expression in Bladder Urothelial Carcinoma
	International Journal of Science and Research (IJSR), 2017

[11]	Immunohistochemical Expression of P63 In Urothelial Carcinoma
	2016

[12]	Clinico-Pathological Correlation of Urothelial Carcinoma of Urinary Bladder with P63 and CK20 Immunostain
	2016

[13]	细胞角蛋白 20 在膀胱癌研究中的进展
	临床医药实践, 2015

[1]	Correlation of HER2 With p53 and p63 in Urothelial Bladder Carcinoma Cureus, 2023 DOI:10.7759/cureus.38018

[2]	Role of Cytokeratin 20 as a Predictive and Prognostic Marker in Urothelial Neoplasms Cureus, 2022 DOI:10.7759/cureus.31607

[3]	A STUDY ON EXPRESSION PROFILE OF BASAL MARKER CD44 AND LUMINAL MARKER CK20 IN UROTHELIAL NEOPLASM AND ITS CORRELATION WITH WHO GRADING AND STAGING OF TUMOUR INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH, 2021 DOI:10.36106/ijsr/9321151

[4]	Evolving concepts and use of immunohistochemical biomarkers in flat non-neoplastic urothelial lesions: WHO 2016 classification update with diagnostic algorithm Biomarkers, 2018 DOI:10.1080/1354750X.2018.1428360

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Open Journal of Pathology

Open Journal of Pathology

Journals Menu

Home

About SCIRP

Service

Policies